-Â Analyst Bruce Jacobs of Deutsche Banc Alex Brown in Boston on the stock prices of the nation's two CPAP heavyweights, respironics and resmed, declining sharply following reports that innomed technologies had logged $20 million in sales commitments for its new nasal int